Research hub
Everything Stocknote has published on Turnaround: 4 research articles covering 4 companies across 4 categories. The latest piece was published on July 10, 2026.
Stellantis’ $38B market cap is below its €46B industrial liquidity, implying 14 global car brands, 40 factories, and 288,000 employees are worth less than nothing. Q1 2026 returned to profitability under CEO Filosa with 12% volume growth — North America leading.
Kraft Heinz's 7.1% dividend yield is pricing in a cut that 1.9x free cash flow coverage doesn't support. New CEO Steve Cahillane's $600M investment cycle follows the same playbook that worked at Kellogg's.
CVS Health's Q1 2026 Aetna medical benefit ratio of 84.6% and five consecutive earnings beats confirm the turnaround is structural, not seasonal. Caremark's 11% revenue growth and 200bps GLP-1 share gain are the hidden growth engine.
Citigroup's Q1 RoTCE of 13.1% already cleared its 2026 target, and the bank is buying back stock near tangible book value of $99.01 — yet it still trades like an unfinished turnaround.
Forensic equity research on US stocks. No spam, unsubscribe anytime.
